{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T14:24:37Z","timestamp":1794666277776,"version":"4.9.1"},"reference-count":35,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"vor","delay-in-days":731,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100004374","name":"Medtronic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004374","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004331","name":"Johnson and Johnson","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004331","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004326","name":"Bayer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004326","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jtcvsonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Thoracic and Cardiovascular Surgery"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.jtcvs.2020.03.039","type":"journal-article","created":{"date-parts":[[2020,3,21]],"date-time":"2020-03-21T03:03:37Z","timestamp":1584759817000},"page":"1030-1039.e4","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Influence of lipoproteins and antiplatelet agents on vein graft patency 1\u00a0year after coronary artery bypass grafting"],"prefix":"10.1016","volume":"163","author":[{"given":"Jiaxi","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunpeng","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minlu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junlong","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaowei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtcvs.2020.03.039_bib1","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1016\/j.jtcvs.2017.09.167","article-title":"The father of coronary artery bypass grafting: Rene Favaloro and the 50th anniversary of coronary artery bypass grafting","volume":"155","author":"Bakaeen","year":"2018","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.jtcvs.2020.03.039_bib2","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1016\/j.jtcvs.2017.12.069","article-title":"Oh, father, where art we? Left internal mammary artery with greater saphenous vein grafts still rules surgical coronary revascularization after 30 years","volume":"155","author":"Stouffer","year":"2018","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.jtcvs.2020.03.039_bib3","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1161\/01.CIR.97.9.916","article-title":"Aortocoronary saphenous vein graft disease: pathogenesis, predisposition, and prevention","volume":"97","author":"Motwani","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.jtcvs.2020.03.039_bib4","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/0735-1097(96)00206-9","article-title":"Coronary bypass graft fate and patient outcome: angiographic follow-up of 5,065 grafts related to survival and reoperation in 1,388 patients during 25 years","volume":"28","author":"Fitzgibbon","year":"1996","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jtcvs.2020.03.039_bib5","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1056\/NEJM198411223112101","article-title":"The relation of risk factors to the development of atherosclerosis in saphenous-vein bypass grafts and the progression of disease in the native circulation. A study 10 years after aortocoronary bypass surgery","volume":"311","author":"Campeau","year":"1984","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtcvs.2020.03.039_bib6","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0735-1097(94)00341-M","article-title":"Relation of saphenous vein graft obstruction to serum cholesterol levels","volume":"25","author":"Daida","year":"1995","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jtcvs.2020.03.039_bib7","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.1093\/eurheartj\/ehw272","article-title":"2016 ESC\/EAS guidelines for the management of dyslipidaemias","volume":"37","author":"Catapano","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jtcvs.2020.03.039_bib8","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1161\/01.CIR.102.2.157","article-title":"Long-term effects on clinical outcomes of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation in the post coronary artery bypass graft trial. Post CABG investigators","volume":"102","author":"Knatterud","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.jtcvs.2020.03.039_bib9","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1056\/NEJM199701163360301","article-title":"The effect of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation on obstructive changes in saphenous-vein coronary-artery bypass grafts","volume":"336","author":"Post Coronary Artery Bypass Graft Trial I","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtcvs.2020.03.039_bib10","first-page":"e340","volume":"110","author":"Eagle","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.jtcvs.2020.03.039_bib11","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1161\/CIRCULATIONAHA.106.174516","article-title":"AHA\/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the National Heart, Lung, and Blood Institute","volume":"113","author":"Smith","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.jtcvs.2020.03.039_bib12","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1056\/NEJMoa050461","article-title":"Intensive lipid lowering with atorvastatin in patients with stable coronary disease","volume":"352","author":"LaRosa","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtcvs.2020.03.039_bib13","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1056\/NEJMoa040583","article-title":"Intensive versus moderate lipid lowering with statins after acute coronary syndromes","volume":"350","author":"Cannon","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtcvs.2020.03.039_bib14","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1001\/jama.292.11.1307","article-title":"Early intensive vs a delayed conservative simvastatin strategy in patients with acute coronary syndromes: phase Z of the A to Z trial","volume":"292","author":"de Lemos","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.jtcvs.2020.03.039_bib15","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1093\/eurheartj\/ehu278","volume":"35","author":"Windecker","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jtcvs.2020.03.039_bib16","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1093\/ejcts\/ezx314","article-title":"2017 EACTS guidelines on perioperative medication in adult cardiac surgery","volume":"53","author":"Sousa-Uva","year":"2018","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.jtcvs.2020.03.039_bib17","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1517\/14740330903188413","article-title":"Statins and coronary artery bypass graft surgery: preoperative and postoperative efficacy and safety","volume":"8","author":"Kulik","year":"2009","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.jtcvs.2020.03.039_bib18","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1001\/jama.2016.0548","article-title":"High-dose perioperative atorvastatin and acute kidney injury following cardiac surgery: a randomized clinical trial","volume":"315","author":"Billings","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.jtcvs.2020.03.039_bib19","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1056\/NEJMoa1507750","article-title":"Perioperative rosuvastatin in cardiac surgery","volume":"374","author":"Zheng","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtcvs.2020.03.039_bib20","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/j.athoracsur.2011.04.107","article-title":"Statin therapy and saphenous vein graft disease after coronary bypass surgery: analysis from the CASCADE randomized trial","volume":"92","author":"Kulik","year":"2011","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.jtcvs.2020.03.039_bib21","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1016\/j.athoracsur.2009.06.009","article-title":"Efficacy of aggressive lipid controlling therapy for preventing saphenous vein graft disease","volume":"88","author":"Hata","year":"2009","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.jtcvs.2020.03.039_bib22","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1001\/jama.2018.3197","article-title":"Effect of ticagrelor plus aspirin, ticagrelor alone, or aspirin alone on saphenous vein graft patency 1 year after coronary artery bypass grafting: a randomized clinical trial","volume":"319","author":"Zhao","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.jtcvs.2020.03.039_bib23","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.jacc.2014.12.018","volume":"66","author":"Hicks","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jtcvs.2020.03.039_bib24","first-page":"e1082","article-title":"2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA guideline on the management of blood cholesterol","volume":"139","author":"Grundy","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.jtcvs.2020.03.039_bib25","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1056\/NEJMoa1410489","article-title":"Ezetimibe added to statin therapy after acute coronary syndromes","volume":"372","author":"Cannon","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtcvs.2020.03.039_bib26","doi-asserted-by":"crossref","first-page":"3576","DOI":"10.1093\/eurheartj\/ehw377","article-title":"The benefit of adding ezetimibe to statin therapy in patients with prior coronary artery bypass graft surgery and acute coronary syndrome in the IMPROVE-IT trial","volume":"37","author":"Eisen","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jtcvs.2020.03.039_bib27","doi-asserted-by":"crossref","first-page":"2866","DOI":"10.1001\/jama.294.22.2866","article-title":"Prognostic value of serial B-type natriuretic peptide testing during follow-up of patients with unstable coronary artery disease","volume":"294","author":"Morrow","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.jtcvs.2020.03.039_bib28","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1016\/j.jacc.2007.12.054","article-title":"Intensive lipid-lowering with atorvastatin for secondary prevention in patients after coronary artery bypass surgery","volume":"51","author":"Shah","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jtcvs.2020.03.039_bib29","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jtcvs.2018.05.123","article-title":"Intensive versus moderate statin therapy and early graft occlusion after coronary bypass surgery: the aggressive cholesterol therapy to inhibit vein graft events randomized clinical trial","volume":"157","author":"Kulik","year":"2019","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.jtcvs.2020.03.039_bib30","first-page":"466","article-title":"Comparison of secondary prevention status between percutaneous coronary intervention and coronary artery bypass patients","volume":"109","author":"Gao","year":"2017","journal-title":"Arq Bras Cardiol"},{"key":"10.1016\/j.jtcvs.2020.03.039_bib31","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1177\/2047487318812962","article-title":"Attainment of lipid goals and long-term mortality after coronary-artery bypass surgery","volume":"26","author":"Zafrir","year":"2019","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.jtcvs.2020.03.039_bib32","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1161\/CIRCULATIONAHA.112.145334","article-title":"Statins as antithrombotic drugs","volume":"127","author":"Violi","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.jtcvs.2020.03.039_bib33","series-title":"Summary of product characteristics","author":"Ticagrelor (Brilique)","year":"2010"},{"key":"10.1016\/j.jtcvs.2020.03.039_bib34","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1161\/CIR.0b013e3181d8d929","article-title":"Role of ticagrelor in clopidogrel nonresponders: resistance is futile?","volume":"121","author":"Tapp","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.jtcvs.2020.03.039_bib35","doi-asserted-by":"crossref","first-page":"1273042","DOI":"10.1155\/2017\/1273042","article-title":"Small dense low-density lipoprotein as biomarker for atherosclerotic diseases","volume":"2017","author":"Ivanova","year":"2017","journal-title":"Oxid Med Cell Longev"}],"container-title":["The Journal of Thoracic and Cardiovascular Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022522320306413?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022522320306413?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T17:17:06Z","timestamp":1758388626000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022522320306413"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":35,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["S0022522320306413"],"URL":"https:\/\/doi.org\/10.1016\/j.jtcvs.2020.03.039","relation":{},"ISSN":["0022-5223"],"issn-type":[{"value":"0022-5223","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Influence of lipoproteins and antiplatelet agents on vein graft patency 1\u00a0year after coronary artery bypass grafting","name":"articletitle","label":"Article Title"},{"value":"The Journal of Thoracic and Cardiovascular Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtcvs.2020.03.039","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 by The American Association for Thoracic Surgery","name":"copyright","label":"Copyright"}]}}